HMP Global October 28, 2025
In a session at AMCP Nexus 2025, Steven Kheloussi, PharmD, MBA, FAMCP, and Jennifer Billings, PharmD, BCGP, provided a comprehensive overview of the rapidly evolving precision medicine landscape and the payer considerations that accompany it. The discussion framed precision medicine as a data-driven, individualized approach to disease prevention and treatment—where genetic, environmental, and lifestyle factors guide therapy selection.
Kheloussi emphasized that this rational therapeutic approach underpins the work of managed care professionals. Importantly, he differentiated precision medicine from personalized medicine, the latter encompassing broader patient factors such as age, gender, and socioeconomic status.
Why Precision Medicine Matters
The presenters cited a growing body of evidence showing improved survival in patients—particularly those with non-small cell lung cancer—who receive first-line treatments aligned...
Today's Sponsors
Today's Sponsor